In today’s briefing:
- BioNote IPO Preview
BioNote IPO Preview
- BioNote, a Korean company specializing in bio contents and animal diagnostics, is getting ready for an IPO in November.
- The IPO price range is from 18,000 won to 22,000 won per share. The IPO offering amount is from 234 billion won to 286 billion won.
- At the high end of IPO price, its market cap would be 2.3 trillion won. Using annualized net profit of 597 billion won, this would suggest a P/E of 3.9x.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
